Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alfonso Iorio

Showing results (41-50 of 304) with videos related to

Pageof 31
Sort By:
Current Pharmaceutical Design|September 23, 2010
Residual vein thrombosis and D-dimer for optimizing duration of anticoagulation in idiopathic deep vein thrombosisAlessandra Malato, Giorgia Saccullo, Alfonso Iorio, et al.
Expert Opinion on Drug Metabolism & Toxicology|August 20, 2016
The use of pharmacokinetics in dose individualization of factor VIII in the treatment of hemophilia AAlanna McEneny-King, Alfonso Iorio, Gary Foster, et al.
Research and Practice in Thrombosis and Haemostasis|March 9, 2023
Prevalence of selected bleeding and thrombotic events in persons with hemophilia versus the general population: A scoping reviewAmy D Shapiro, Brandon M Hardesty, Flora Peyvandi, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 7, 2025
Exploring the Impact of Laboratory Reagents on Pharmacokinetic ProfilingPierre Chelle, Dagmar Hajducek, Emma Iserman, et al.
Thrombosis and Haemostasis|January 16, 2010
Bone mineral density in haemophilia patients. A meta-analysisAlfonso Iorio, Gianluigi Fabbriciani, Maura Marcucci, et al.
Thrombosis and Haemostasis|May 29, 2015
Evaluation of safety and effectiveness of factor VIII treatment in haemophilia A patients with low titre inhibitors or a personal history of inhibitor. Patient Data Meta-analysis of rAFH-PFM Post-Authorization Safety StudiesVadim Romanov, Maura Marcucci, Ji Cheng, et al.
Annals of Internal Medicine|June 2, 2020
Context and Approach in Reporting Evaluations of Electronic Health Record-Based Implementation ProjectsR Brian Haynes, Guilherme Del Fiol, Matthew Michelson, et al.
Thrombosis Research|November 6, 2019
A comparison of methods for prediction of pharmacokinetics across factor concentrate switching in hemophilia patientsJacky K Yu, Alfonso Iorio, Pierre Chelle, et al.
JMIR Research Protocols|December 9, 2016
Data Analysis Protocol for the Development and Evaluation of Population Pharmacokinetic Models for Incorporation Into the Web-Accessible Population Pharmacokinetic Service - Hemophilia (WAPPS-Hemo)Alanna McEneny-King, Gary Foster, Alfonso Iorio, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 2, 2021
Pharmacokinetic implications of dosing emicizumab based on vial size: A simulation studyJacky K Yu, Alfonso Iorio, Pierre Chelle, et al.
Pageof 31

Showing results (41-50 of 304) with videos related to

Sort By:
Pageof 31
Current Pharmaceutical Design|September 23, 2010
Residual vein thrombosis and D-dimer for optimizing duration of anticoagulation in idiopathic deep vein thrombosisAlessandra Malato, Giorgia Saccullo, Alfonso Iorio, et al.
Expert Opinion on Drug Metabolism & Toxicology|August 20, 2016
The use of pharmacokinetics in dose individualization of factor VIII in the treatment of hemophilia AAlanna McEneny-King, Alfonso Iorio, Gary Foster, et al.
Research and Practice in Thrombosis and Haemostasis|March 9, 2023
Prevalence of selected bleeding and thrombotic events in persons with hemophilia versus the general population: A scoping reviewAmy D Shapiro, Brandon M Hardesty, Flora Peyvandi, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 7, 2025
Exploring the Impact of Laboratory Reagents on Pharmacokinetic ProfilingPierre Chelle, Dagmar Hajducek, Emma Iserman, et al.
Thrombosis and Haemostasis|January 16, 2010
Bone mineral density in haemophilia patients. A meta-analysisAlfonso Iorio, Gianluigi Fabbriciani, Maura Marcucci, et al.
Thrombosis and Haemostasis|May 29, 2015
Evaluation of safety and effectiveness of factor VIII treatment in haemophilia A patients with low titre inhibitors or a personal history of inhibitor. Patient Data Meta-analysis of rAFH-PFM Post-Authorization Safety StudiesVadim Romanov, Maura Marcucci, Ji Cheng, et al.
Annals of Internal Medicine|June 2, 2020
Context and Approach in Reporting Evaluations of Electronic Health Record-Based Implementation ProjectsR Brian Haynes, Guilherme Del Fiol, Matthew Michelson, et al.
Thrombosis Research|November 6, 2019
A comparison of methods for prediction of pharmacokinetics across factor concentrate switching in hemophilia patientsJacky K Yu, Alfonso Iorio, Pierre Chelle, et al.
JMIR Research Protocols|December 9, 2016
Data Analysis Protocol for the Development and Evaluation of Population Pharmacokinetic Models for Incorporation Into the Web-Accessible Population Pharmacokinetic Service - Hemophilia (WAPPS-Hemo)Alanna McEneny-King, Gary Foster, Alfonso Iorio, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 2, 2021
Pharmacokinetic implications of dosing emicizumab based on vial size: A simulation studyJacky K Yu, Alfonso Iorio, Pierre Chelle, et al.
Pageof 31